Single-cell Omics Market Players:
- Ultima Genomics, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- 10x Genomics, Inc.
- Becton, Dickinson and Company (BD)
- CELLENION
- PerkinElmer Inc.
- ANGLE plc
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Mission Bio, Inc.
- Standard BioTools Inc.
- Scale Biosciences, Inc.
- Takara Bio USA Holdings, Inc.
Key players in the single-cell omics market are changing their dynamics by incorporating advanced technologies such as multi omics, AI-powered analysis, and spatial sequencing. Their focus is concentrated on improving the performance and utility of their products by leveraging their capabilities. In this regard, in March 2024, BioSkryb Genomics commercialized its new ResolveDNA Whole Genome, ResolveOME Whole Genome, and Transcriptome Single-Cell Core Kits in the U.S. and international market, offering fast and seamless workflow. Similarly, in October 2024, 10x Genomics two new Chromium products, GEM-X Flex and GEM-X Universal Multiplex, to upscale the performance, workflow, and cost effectiveness for researchers associated with single-cell analysis. Such key players are:
